Magnetic nanocrystals have been investigated extensively in the past several years for several potential applications, such as information technology, MRI contrast agents, and for drug conjugation and delivery. A specific property of interest in biomedicine is magnetic hyperthermia—an increase in temperature resulting from the thermal energy released by magnetic nanocrystals in an external alternating magnetic field. Iron oxide nanocrystals of various sizes and morphologies were synthesized and tested for specific losses (heating power) using frequencies of 111.1 kHz and 629.2 kHz, and corresponding magnetic field strengths of 9 and 25 mT. Polymorphous nanocrystals as well as spherical nanocrystals and nanowires in paramagnetic to ferromagnetic size range exhibited good heating power. A remarkable 30 °C temperature increase was observed in a nanowire sample at 111 kHz and magnetic field of 25 mT (19.6 kA/m), which is very close to the typical values of 100 kHz and 20 mT used in medical treatments.
References
[1]
Pradhan, P.; Giri, J.; Samanta, G.; Dev Sarma, H.; Prasad Mishra, K.; Bellare, J.; Banerjee, R.; Bahadur, D. Comparative evaluation of heating ability and biocompatibility of different ferrite-based magnetic fluids for hyperthermia application. J. Biomed. Mater. Res. B Appl. Biomater. 2007, 81B, 12–22.
[2]
Duguet, E.; Vasseur, S.; Mornet, S.; Devoisselle, J.-M. Magnetic nanoparticles and their applications in medicine. Nanomedicine 2006, 1, 157–168.
[3]
Nitin, N.; LaConte, L.E.W.; Zurkiya, O.; Hu, X.; Bao, G. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J. Biol. Inorganic Chem. 2004, 9, 706–712.
[4]
Sun, C.; Lee, J.S.H.; Zhang, M. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 2008, 60, 1252–1265.
[5]
Johannsen, M.; Gneveckow, U.; Taymoorian, K.; Thiesen, B.; Wald？fner, N.; Scholz, R.; Jung, K.; Jordan, A.; Wust, P.; Loening, S.A. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial. Int. J. Hyperthermia. 2007, 23, 315–323.
[6]
Van Landeghem, F.K.H.; Maier-Hauff, K.; Jordan, A.; Hoffmann, K.-T.; Gneveckow, U.; Scholz, R.; Thiesen, B.; Brück, W.; von Deimling, A. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 2009, 30, 52–57.
[7]
Fortin, J.-P.; Gazeau, F.; Wilhelm, C. Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles. Eur. Biophys. J. 2008, 37, 223–228.
[8]
Saniei, N. Hyperthermia and cancer treatment. Heat Transf. Eng. 2009, 30, 915–917.
[9]
Purushotham, S.; Chang, P.E.J.; Rumpel, H.; Kee, I.H.C.; Ng, R.T.H.; Chow, P.K.H.; Tan, C.K.; Ramanujan, R.V. Thermoresponsive core–shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology 2009, 20, 305101–305111.
[10]
McGill, S.; Cuylear, C.; Adolphi, N.; Osiński, M.; Smyth, H. Enhanced drug transport through alginate biofilms using magnetic nanocrystals. In Colloidal Quantum Dots for Biomedical Applications IV; Osiński, M., Jovin, T.M., Yamamoto, K., Eds.; SPIE: Bellingham, WA, USA, 2009; Volume 7189, p. 718918.
[11]
Park, J.; An, K.; Hwang, Y.; Park, J.-G.; Noh, H.-J.; Kim, J.-Y.; Park, J.-H.; Hwang, N.-M.; Hyeon, T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater. 2004, 3, 891–895.
[12]
Hergt, R.; Andra, W.; d'Ambly, C.G.; Hilger, I.; Kaiser, W.A.; Richter, U.; Schmidt, H.-G. Physical limits of hyperthermia using magnetite fine particles. IEEE Trans. Magn. 1998, 34, 3745–3754.
[13]
Wust, P.; Gneveckow, U.; Johannsen, M.; Boehmer, D.; Henkel, T.; Kahmann, F.; Sehouli, J.; Felix, R.; Ricke, J.; Jordan, A. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int. J. Hyperthermia 2006, 22, 673–685.
[14]
Mehdaoui, B.; Meffre, A.; Carrey, J.; Lachaize, S.; Lacroix, L.-M.; Gougeon, M.; Chaudret, B.; Respaud, M. Optimal size of nanoparticles for magnetic hyperthermia: A combined theoretical and experimental study. Adv. Funct. Mater. 2011, 21, 4573–4581.
[15]
Bronstein, L.; Huang, X.; Retrum, J.; Schumucker, A.; Pink, M.; Stein, B.D.; Dragnea, B. Influence of iron oleate complex structure on iron oxide manoparticle formation. Chem. Mater. 2007, 19, 3624–3632.
[16]
Palchoudhury, S.; An, W.; Xu, Y.; Qin, Y.; Zhang, Z.; Chopra, N.; Holler, R.A.; Turner, C.H.; Bao, Y. Synthesis and growth mechanism of iron oxide nanowhiskers. Nano Lett. 2011, 11, 1141–1146.
[17]
Shtykova, V.; Huang, X.; Remmes, N.; Baxter, D.; Stein, B.; Dragnea, B.; Svergun, D.I.; Bronstein, L.M. Structure and properties of iron oxide nanoparticles encapsulated by phospholipids with poly (ethylene glycol) tails. J. Phys. Chem. C 2007, 111, 18 078–18 086.
[18]
Hergt, R.; Dutz, S.; Muller, R.; Zeisberger, M. Magnetic particle hyperthermia: Nanoparticle magnetism and materials development for cancer therapy. J. Phys. Condens. Matter 2006, 18, S2919–S2934.
